Researcher Sponsorship: Breast Cancer

Sponsor the breast cancer research team

Month after month, your sponsorship accelerates breast cancer research toward new breakthroughs

Despite significant progress in research, breast cancer remains a major public health issue: every year in France, more than 58,000 women are newly diagnosed. Although the majority of them will recover, some will face metastatic disease resistant to standard treatments or a relapse, and others will not survive.

It is for these women that the cutting-edge expertise of Professor Fabrice André and Dr. Olivia Fromigué’s research team is absolutely essential; it is for them that your sponsorship makes a direct difference.

Through your sponsorship, become a driving force for innovation and accelerate breast cancer research for the direct benefit of patients!

Innovating to better treat metastatic breast cancer: three flagship research programs:

● Characterizing the immunological abnormalities involved in the progression of breast
cancer ● Understanding the mechanisms of resistance to available
treatments ● Developing new therapies targeted at the identified abnormalities

Goal: to develop new personalized therapeutic strategies against metastatic breast cancer

Benefits for patients:

● Administer the most effective treatment upon diagnosis
● Predict the risk of relapse
● Improve patient survival

Annual program budget: €150,000

 

Becoming a sponsor means taking part in a major scientific adventure every day

What if, for just €8.50 a month*, you could help accelerate breast cancer research?

With a regular donation of at least €25 per month (or €8.50 after tax deduction), you become a valued partner of your research team.

Your sponsorship provides essential support for bringing innovative breast cancer projects to fruition.

 

Our breast
cancer research will move forward thanks to you

Prof. Fabrice André, Director of INSERM Unit U981 and oncologist with the Breast Pathology Committee

The regular support we receive from our sponsors is essential… The more progress we make, the more we realize that every case of breast cancer is unique. Gaining a better understanding of tumor genes, identifying mechanisms of treatment resistance, characterizing the immunological abnormalities involved in cancer progression, and understanding the genetic factors responsible for treatment side effects are key research areas to help our patients in their fight. Sponsorship is essential for carrying out innovative research projects and funding feasibility studies that cannot secure immediate public funding because they are considered too innovative.

Dr. Olivia Fromigué, Researcher, Inserm CR1 Unit

Sponsorships are invaluable because they give us flexibility in our day-to-day expenses, allowing us to respond more quickly to major breakthroughs in any of the avenues we’re exploring. Sponsorship is a key driver in the fight against breast cancer. Through their regular support, our sponsors provide long-term backing for our research, and their generosity further strengthens our resolve to combat this disease together. Our regular meetings with our sponsors are always very enriching opportunities for sharing and discussion. It’s an extraordinary chance to answer their questions, share our hopes, and update them on the progress we’ve made thanks to their support.

 

 

*after a 66% tax deduction

 

 Colorectal Cancer Childhood Cancer Gynecological Cancers Living Better with Cancer Skin Cancer Lung Cancer Prostate Cancer Sarcomas Breast Cancer Brain Tumors